Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-24 @ 11:39 PM
NCT ID: NCT00200551
Eligibility Criteria: Inclusion Criteria: * Patient who is a candidate for a first cadaver renal transplantation and included on the national list of the Etablissement Français des Greffes * Man or woman aged between 18 and 65 years * Women of reproductive age must agree to use a reliable contraceptive method throughout the first year of the study * Donor aged between 18 and 65 years * Patient who has been given full information about the study and who has given his written informed consent to take part in it. Exclusion Criteria: * Women who are pregnant or breast-feeding * Patient with an immunological risk considered high and defined as a percentage of anti-HLA antibodies of ³20% (previous or recent determination of T lymphocytes) * Patient with a history of allergy to rabbit proteins * Cold ischaemia time of more than 36 hours * Patient allergic to macrolide antibiotics, to tacrolimus or to MMF * Patient on immunosuppressant treatment before transplantation * Patient suffering from a malignant neoplasm or with a history of malignant neoplasia, with the exception of treated baso- or spinocellular cancers * Patient waiting for another transplant in addition to the kidney * Patient who has already received an organ or tissue graft * Leukocyte count \<2000/mm3 and/or platelet count \<50 000/mm3 * Patient suffering from focal glomerulonephritis
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT00200551
Study Brief:
Protocol Section: NCT00200551